• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial A

  2026-07-26

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent with potent activity against Gram-positive, Gram-negative, and intracellular pathogens. Its efficacy in both extracellular and intracellular bactericidal assays, including against Mycobacterium avium complex, is well-established. This compound offers a robust tool for research into antibiotic resistance and infection models.

• Discovery and Characterization of MK 0893: A Potent Glucagon

  2026-07-25

  The reference study reports the discovery and detailed characterization of MK 0893, a potent, selective, and orally bioavailable glucagon receptor antagonist. By structurally optimizing a lead scaffold, the researchers achieved high affinity and selectivity for GCGR, with significant efficacy in preclinical models of type 2 diabetes. These findings advance the understanding of glucagon receptor modulation and provide a robust tool for metabolic disease research.

• Reversing Obesity-Linked Deficits in Gut Stretch Satiety Sig

  2026-07-24

  This study uncovers how weight loss, via diet or surgery, restores the ability of intestinal stretch to suppress food intake and improve glucose regulation—functions that are impaired in obesity. The findings highlight a GLP-1–independent mechanism by which gastrointestinal mechanosensation modulates satiety and metabolic homeostasis, offering new insight into type II diabetes treatment research.

• FGFR–TGFβ/PI3K/AKT Crosstalk Regulates Periostin in HER2+ Br

  2026-07-24

  Labrèche et al. uncover a novel regulatory axis governing periostin expression in HER2/neu-positive breast cancer cells, demonstrating that crosstalk between FGFR, TGFβ, and PI3K/AKT pathways fine-tunes this matricellular gene. Their mechanistic insights clarify how distinct signaling contexts can drive tumor cell–specific periostin acquisition, with implications for disease aggressiveness and therapeutic targeting.

• LNP-mRNA Vaccine Targeting Chlamydia psittaci: Immunogenicit

  2026-07-23

  This study presents an mRNA vaccine encoding the major outer membrane protein (MOMP) of Chlamydia psittaci, delivered via lipid nanoparticles, which induced strong protective immune responses in BALB/c mice. The research offers a practical foundation for mRNA vaccine strategies against zoonotic respiratory pathogens and highlights the relevance of advanced mRNA synthesis approaches.

• Trelagliptin Succinate: Protocol Optimization for Diabetes R

  2026-07-23

  Trelagliptin succinate (SYR-472 succinate) streamlines glucose regulation studies and enhances data reproducibility in diabetes mellitus research. This guide delivers workflow enhancements, troubleshooting insights, and protocol parameters tailored for both cell-based and in vivo models, drawing on validated analytical and biological evidence.

• Technical Use of Annexin V-FITC/7-AAD Apoptosis Kit (K1139)

  2026-07-22

  The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid and reliable discrimination of apoptotic and necrotic cells in cell death and viability workflows. It is best suited for fluorescence-based analysis by flow cytometry or microscopy and is not intended for mechanistic pathway dissection or non-standard cell types.

• MK 0893: Selective Glucagon Receptor Antagonist for Diabetes

  2026-07-22

  MK 0893 is a potent, reversible glucagon receptor antagonist optimized for type 2 diabetes research. It demonstrates nanomolar inhibition of human GCGR, robust selectivity, and efficacy in both cell-based and animal models according to peer-reviewed and product sources.

• Scenario-Driven Solutions with EZ Cap™ Cas9 mRNA (m1Ψ): SKU

  2026-07-21

  This article delivers a scenario-driven, evidence-based guide for optimizing CRISPR-Cas9 genome editing using EZ Cap™ Cas9 mRNA (m1Ψ) (SKU R1014). Drawing on laboratory challenges, peer-reviewed data, and protocol best practices, we demonstrate how this advanced mRNA with Cap1 structure empowers reliable, reproducible genome editing in mammalian cells, while minimizing innate immune activation.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Workflows

  2026-07-21

  Discover how Sitagliptin phosphate monohydrate enables reproducible DPP-4 inhibition, precise incretin modulation, and advanced metabolic modeling. This guide delivers actionable workflow enhancements and troubleshooting for type II diabetes research, grounded in the latest mechanistic advances.

• Reliable Cell Signaling with Anti-RPS6 (7B10) Mouse Monoclon

  2026-07-20

  This article addresses critical challenges in cell proliferation and viability assays by exploring scenario-driven questions about the Anti-RPS6 (7B10) Mouse Monoclonal Antibody (SKU MA4974). It demonstrates, with data-backed analysis, how this antibody delivers reproducible results across workflows relevant to cancer biology and ribosome biogenesis research. Researchers will gain practical insight into assay optimization, vendor selection, and the robust scientific value of SKU MA4974.

• BI 2536: PLK1 Inhibitor Applications in Cell Cycle Arrest St

  2026-07-20

  BI 2536 stands out as a nanomolar-potency, highly selective PLK1 inhibitor, enabling precise cell cycle and apoptosis assays in cancer research. This article details experimental workflows, practical troubleshooting, and the latest mechanistic insights, translating complex checkpoint biology into actionable protocols.

• Next-Generation Firefly Luciferase mRNA: Immune Evasion, Sta

  2026-07-19

  Explore how Firefly Luciferase mRNA with 5-moUTP modification redefines assay precision and immune evasion. This in-depth article reveals unique mechanistic advantages and practical guidance beyond standard workflows.

• Anagliptin (SK-0403): Reliable DPP-4 Inhibition for Vascular

  2026-07-18

  This scenario-driven guide details how Anagliptin (SK-0403) (SKU BA7300) addresses laboratory challenges in vasorelaxant and DPP-4 inhibition research. By grounding workflow decisions in peer-reviewed data and real protocol considerations, the article demonstrates the compound's reproducibility and technical clarity for biomedical scientists.

• EdU Imaging Kits (Cy5): Precision Tools for Cell Cycle Resea

  2026-07-17

  Explore how EdU Imaging Kits (Cy5) revolutionize cell proliferation assays through advanced click chemistry, enabling sensitive, morphology-preserving detection of S-phase DNA synthesis. Uncover new insights for experimental design and translational research.

8644 records 5/577 page Previous Next 12345 下5页 Last page